Details for Patent: 10,702,573

Which drugs does patent 10,702,573 protect, and when does it expire?

Patent 10,702,573 protects REZZAYO and is included in one NDA.

This patent has fifty patent family members in twenty-three countries.

Summary for Patent: 10,702,573

Title:	Dosing regimens for echinocandin class compounds
Abstract:	The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
Inventor(s):	Balasingam Radhakrishnan, Kenneth Duke James, JR., Anuradha Vaidya, Karen Polowy
Assignee:	Seachaid Pharmaceuticals LLC, Cidara Therapeutics Inc
Application Number:	US16/017,427
Patent Claim Types: see list of patent claims

Analyzing the Scope and Claims of United States Patent 10,702,573

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This analysis will delve into the specifics of United States Patent 10,702,573, exploring its claims, scope, and the broader patent landscape.

Patent Basics

Before diving into the specifics of US Patent 10,702,573, it is essential to understand the general process and components of a patent.

• Patent Process: The patent process involves filing an application, undergoing examination, and if approved, maintaining the patent through fees and other requirements[5].
• Patent Claims: Claims are the heart of a patent, defining the scope of the invention and what is protected. They must be clear, concise, and supported by the patent's description[5].

Patent 10,702,573 Overview

To analyze the scope and claims of US Patent 10,702,573, one must first identify the key elements of the patent.

• Title and Abstract: The title and abstract provide a brief overview of the invention. For example, if the patent is related to a new drug, the title might reflect the compound or method, and the abstract would summarize its purpose and novelty.
• Background and Summary: These sections provide context and a detailed summary of the invention, including its background, advantages, and how it differs from prior art.

Claims Analysis

The claims section is the most critical part of a patent as it defines the legal boundaries of the invention.

Independent and Dependent Claims

• Independent Claims: These claims stand alone and define the invention without reference to other claims. They are typically broader and more general[3].
• Dependent Claims: These claims refer back to and further limit the independent claims, often adding specific details or features.

Claim Language and Scope

The scope of a patent is often measured by metrics such as independent claim length and independent claim count. Broader claims can be more contentious as they may encompass a wider range of technologies, potentially leading to licensing and litigation issues[3].

Patent Scope and Breadth

The scope of a patent, as defined by its claims, is a critical factor in determining its validity and enforceability.

• Narrow vs. Broad Claims: Narrower claims are generally associated with a higher probability of grant and a shorter examination process. Broader claims, while potentially more valuable, can be more challenging to defend and may face more opposition during the examination process[3].

Examination Process and Allowance Rates

The examination process at the USPTO can provide insights into the patent's validity and the likelihood of its claims being allowed.

• First-Action Allowance Rate: This rate indicates the proportion of applications allowed without further examination. A higher rate suggests that the claims are well-defined and supported by the patent's description[4].
• Progenitor Allowance Rate: This rate reflects the proportion of applications allowed without any continuation procedures. It gives a clearer picture of the initial strength of the claims[4].

Geographic and Technological Trends

Understanding the broader patent landscape can provide context to the significance and positioning of US Patent 10,702,573.

• Geographic Allocation: Patents are often allocated to countries based on the residence of the inventors or the receiving office for PCT applications. This can help in analyzing global patenting trends and the impact of the patent on different regions[1].
• Technological Categories: Patents are categorized into technology fields such as Chemical, Drugs and Medical, Electrical and Electronics, etc. This categorization helps in understanding the technological context and the innovation landscape within which the patent operates[1].

Regulatory and Legal Considerations

Patents, especially those related to pharmaceuticals or medical devices, must navigate regulatory approvals and legal challenges.

• Regulatory Review Period: For patents related to drug products, the regulatory review period can significantly impact the patent term extension. The USPTO applies statutory limitations to calculate the actual period for patent extension[2].
• Petitions and Appeals: Any disputes or challenges to the patent can be addressed through petitions and appeals processes at the USPTO, including the Patent Trial and Appeal Board (PTAB)[5].

Key Takeaways

• Claims Definition: The claims section is crucial and must be clear, concise, and well-supported.
• Scope and Breadth: Narrower claims are generally more favorable in terms of grant probability and examination duration.
• Examination Process: Understanding the allowance rates and examination process can provide insights into the patent's validity.
• Geographic and Technological Context: Allocating patents to countries and categorizing them into technological fields helps in analyzing global trends and innovation landscapes.
• Regulatory Considerations: Patents must comply with regulatory requirements, especially in fields like pharmaceuticals.

FAQs

1. What are the key components of a patent application?

   • The key components include the title, abstract, background, summary, description, claims, and drawings[5].

2. How are patent claims categorized?

   • Patent claims are categorized into independent and dependent claims, with independent claims standing alone and dependent claims referring back to independent claims[3].

3. What metrics are used to measure patent scope?

   • Metrics such as independent claim length and independent claim count are used to measure patent scope[3].

4. How does the USPTO allocate patents to countries?

   • Patents are allocated based on the residence of the inventors or the receiving office for PCT applications[1].

5. What is the significance of the regulatory review period in patent term extension?

   • The regulatory review period can significantly impact the patent term extension, with the USPTO applying statutory limitations to calculate the actual extension period[2].

Sources

1. Invention, Knowledge Transfer, and Innovation - National Science Foundation
2. Federal Register, Volume 89 Issue 179 - U.S. Government Publishing Office
3. Patent Claims and Patent Scope - SSRN
4. What Is the Probability of Receiving a US Patent? - Yale Journal of Law and Technology
5. Patents - USPTO - United States Patent and Trademark Office

Drugs Protected by US Patent 10,702,573

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mundipharma	REZZAYO	rezafungin acetate	POWDER;INTRAVENOUS	217417-001	Mar 22, 2023		RX	Yes	Yes	10,702,573		Y	Y		TREATMENT OF CANDIDEMIA AND INVASIVE CANDIDIASIS WITH REZAFUNGIN BY INTRAVENOUS ADMINISTRATION

International Family Members for US Patent 10,702,573

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013235512
Australia	2017201758
Australia	2019201072